Results 101 to 110 of about 3,018 (199)

Management of Diffuse Carcinomatosis of the Bone Marrow from Occult Breast Cancer with Abemaciclib and Letrozole: Case Report and Literature Review

Indian Journal of Medical and Paediatric Oncology
Occult breast cancer (OBC) signifies a rare subset of breast cancers, accounting for only 0.3 to 1% of all breast cancers. Diagnosing cancer of unknown primary requires a comprehensive approach, including histological examination, immunohistochemistry ...
Ketan Makwana, Shaunak Valame
doaj   +1 more source

Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial [PDF]

, 2017
Background The cardiac safety of trastuzumab concurrent with pegylated liposomal doxorubicin (PLD) in an adjuvant breast cancer treatment regimen is unknown.
Bermejo, B., Canon, J. L., Chirgwin, J., Ferrandina, G., Jackisch, C., Provencher, L., Rayson, D., Richel, D. J., Srinivasan, S., Suter, T. M., Temizkan, M., Torres, A., van den Bosch, J., van der Vegt, S., van Gent, A. M., Vivanco, G. L., Wildiers, H., Zhang, L.   +17 more
core  

Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. [PDF]

, 2016
BACKGROUND: Breast cancer comprises several molecular subtypes with different prognoses and possibly different etiology. Reproductive and hormonal factors are associated with breast cancer overall, and with luminal subtypes, but the associations with ...
Dos-Santos-Silva, Isabel, Ellingjord-Dale, Merete, Hofvind, Solveig, Tretli, Steinar, Ursin, Giske, Vos, Linda   +5 more
core   +2 more sources

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

World Journal of Surgical Oncology, 2018
Background Prognosis of breast cancer and success of therapeutic interventions largely rely on the clinico-pathologic and biological characteristics of the tumor and vary due to the heterogeneous nature of breast cancers.
Atif Ali Hashmi, Saher Aijaz, Saadia Mehmood Khan, Raeesa Mahboob, Muhammad Irfan, Narisa Iftikhar Zafar, Mariam Nisar, Maham Siddiqui, Muhammad Muzzammil Edhi, Naveen Faridi, Amir Khan   +10 more
doaj   +1 more source

High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium. [PDF]

, 2016
Automated methods are needed to facilitate high-throughput and reproducible scoring of Ki67 and other markers in breast cancer tissue microarrays (TMAs) in large-scale studies. To address this need, we developed an automated protocol for Ki67 scoring and
Abubakar, Mustapha, Benitez, Javier, Blows, Fiona, Bolla, Manjeet K, Brenner, Herman, Broeks, Annegien, Chang-Claude, Jenny, Couch, Fergus J, Coulson, Penny, Daley, Frances, Devilee, Peter, Dowsett, Mitch, Easton, Douglas, Eccles, Diana, Figueroa, Jonine, Garcia-Closas, Montserrat, Hewitt, Stephen, Hm van Deurzen, Carolien, Hollestelle, Antoinette, Hooning, Maartje J, Howat, William J, Jones, Michael, kConFab Investigators, Lissowska, Jolanta, Mannermaa, Arto, McDuffus, Leigh-Anne, Milne, Roger, Orr, Nick, Pharoah, Paul D, Raza Ali, H, Rudolph, Anja, Schmidt, Marjanka K, Schoemaker, Minouk, Sherman, Mark E, Sinn, Peter, Stegmaier, Christa, Swerdlow, Anthony J, Tollenaar, Rob AEM, van Leeuwen, Flora E, Van't Veer, Laura, Wang, Qin, Wm Martens, John, Zabaglo, Lila   +42 more
core   +2 more sources

Correlation of tumor budding with a novel and other established prognostic parameters in patients with invasive breast carcinoma

Indian Journal of Pathology and Microbiology
Context: Breast cancer is the most common malignancy among women. Established prognostic markers in breast carcinomas include tumor size, histologic grade, nodal status, lymphovascular invasion, perineural invasion, hormone receptor status, HER-2 status,
Neha D. Borde, Yash M. Thesiya, Meera S. Mahajan, Chandrashekhar P. Bhale   +3 more
doaj   +1 more source

Metaplastic Carcinoma Breast in Polycythemic Octogenarian – Lessons Learnt: Case Report

Lietuvos Chirurgija
An 80-year-old lady presented with lump Left breast of 8 months duration. Clinically was aT4b lesion, sonomammogram showed BIRADS V lesion and core needle breast biopsy features were suggestive of metaplastic carcinoma breast of adenosquamous type, ER ...
Swarup Prabhu, Munish Malhotra, Naresh Saidha, Ritu Mehta, Surjeet Dwivedi, Tarun Mohan Gupta   +5 more
doaj   +3 more sources

Impact of Treatment Related Neutropenia on Response to Palbociclib in Metastatic Hormone Positive, her2neu Negative Breast Cancer

Asian Pacific Journal of Cancer Prevention
Cyclin-dependent kinases (CDK4/6) inhibitors play an important role in the management of metastatic hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer. They act by inhibiting the proteins CDK4 and CDK6, which are implicated in the advancement of the cell cycle and unchecked cell proliferation ...
Abdelmottaleb, Al Dandan, Mohammed, Alamer, Alaa Adel, Alsalman, Mohamed, Al Hassan, Ali, Al Mutair, Laid, Nawi, Lasaad, Nesrat, Manal, Aloub, Shimaa Radwan, Younis   +8 more
openaire   +2 more sources

Addressing Global Disparities in Breast Cancer by Transforming Surgical Pathology in Ethiopia: Early Implementation of Immunohistochemistry

JCO Global Oncology
PURPOSESurgical pathology services are essential for breast cancer (BC) diagnosis and treatment. Building capacity in immunohistochemistry (IHC) is urgently needed in sub-Saharan Africa.
Lesley Taylor, Rebecca A. Nelson, Teketel Tadesse Geremew, Meron Gebrekirstos Teklehaimanot, Daniel Schmolze, Alemwosen Teklhaymanot Alem   +5 more
doaj   +1 more source

Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span

Scientific Reports, 2017
Cancer vaccines are less effective at old than at young age because of immunosenescence. Besides, in preliminary observations we showed that the immunization with HER-2/neu DNA plasmid in transgenic young mice (standard immunization, SI) delays but not ...
Mauro Provinciali, Alessandra Barucca, Fiorenza Orlando, Elisa Pierpaoli   +3 more
doaj   +1 more source